Status: Recruiting
Clinical Trial on HIPEC With Mitomycin C in Colon Cancer Peritoneal Metastases (GECOP-MMC)
The aim of this study is to assess whether there are differences in PERITONEAL RECURRENCE in patients with Colon Cancer Peritoneal Metastases treated with complete surgical resection and systemic chemotherapy, with (Group 1) or without (Group 2) HIPEC with Mitomycin-C.
Participants needed: 216
Trial details
Phase: Phase 4Age: 18+Biological sex: AllType: InterventionalSponsor: Hospital Universitario de FuenlabradaUpdated: Oct 9, 2024Locations: 31
Eligibility criteria
Histologically confirmed colon adenocarcinoma, except signet ring cell carcinoma... [+7]
Peritoneal carcinomatosis of any other origin, particularly rectal cancer or app... [+11]